Home > Boards > US OTC > Electronics and components > Xenonics Holdings Inc (XNNHQ)

<u>$XNNHQ: David Lazar revival... wait for it :)</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
makinezmoney Member Profile
Followed By 637
Posts 15,249
Boards Moderated 18
Alias Born 12/10/12
160x600 placeholder
makinezmoney   Monday, 05/20/19 09:46:30 AM
Re: None
Post # of 4280 
$XNNHQ: David Lazar revival... wait for it :)

On April 1, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Xenonics, proper notice having
been given to the officers and directors of Fountain Healthy Aging, Inc. There was no opposition.
On April 1, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary, Treasurer
and Director.
The accompanying financial statements are prepared on the basis of accounting principles generally accepted in the United States of America
(“GAAP”). The Company is a developmentstage enterprise devoting substantial efforts to establishing a new business, financial planning, raising
capital, and research into products which may become part of the Company’s product portfolio. The Company has not realized significant sales
through since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new
business and, even if planned principal operations have commenced, revenues are insignificant.
The accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has
not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund
its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity
funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating
activities, there can be no assurance that the Company will be able to raise additional equity capital, or be successful in the development and
commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not
include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification
of liabilities that may result from the possible inability of the Company to continue as a going concern.

Item 10. Issuer Certification
I, David Lazar, certify that:
I have reviewed this quarterly statement of Xenonics Holdings, Inc.; and
Based on my knowledge, this disclosure statement does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this disclosure statement; and
Based on my knowledge, the financial statements, and other financial information included or
incorporated by reference in this disclosure statement, fairly present in all material respectsthe
financial condition, results of operations and cash flows of the issuer as of, and for, the periods
presented in this disclosure statement.
Date : May 10, 2019
/s/ David Lazar
Chief Executive Officer

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist